Information Journal Paper
APA:
Copy. (2017). NF-kB as a mediator of brain inflammation in AD. CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS (CNS AND NEUROLOGICAL DISORDERS DRUG TARGETS), 16(1), 0-0. SID. https://sid.ir/paper/670426/en
Vancouver:
Copy. NF-kB as a mediator of brain inflammation in AD. CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS (CNS AND NEUROLOGICAL DISORDERS DRUG TARGETS)[Internet]. 2017;16(1):0-0. Available from: https://sid.ir/paper/670426/en
IEEE:
Copy, “NF-kB as a mediator of brain inflammation in AD,” CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS (CNS AND NEUROLOGICAL DISORDERS DRUG TARGETS), vol. 16, no. 1, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/670426/en